1. Home
  2. Analysis

Gastrointestinal candidiasis and drugs of ingredients of voriconazole (a real world drug study)


Summary:

Gastrointestinal candidiasis is found among people who take drugs with ingredients of voriconazole, especially for people who are male, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 33,501 people who have side effects when taking drugs with ingredients of voriconazole from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Vfend, Voriconazole.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 02, 2026

33,501 people reported to have side effects when taking drugs with ingredients of voriconazole.
Among them, 14 people (0.04%) have Gastrointestinal candidiasis

What is Gastrointestinal candidiasis?

Gastrointestinal candidiasis (fungal infection of gastrointestinal tract) is found to be associated with 76 drugs and 164 conditions by eHealthMe. Check the latest studies of Gastrointestinal candidiasis.

Number of reports submitted per year:

Could drugs with ingredients of voriconazole cause Gastrointestinal candidiasis?

Time on drugs with ingredients of voriconazole when people have Gastrointestinal candidiasis *:

  • < 1 month: 60 %
  • 1 - 6 months: 40 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Gastrointestinal candidiasis when taking drugs with ingredients of voriconazole *:

  • female: 30.77 %
  • male: 69.23 %

Age of people who have Gastrointestinal candidiasis when taking drugs with ingredients of voriconazole *:

  • 0-1: 0.0 %
  • 2-9: 7.69 %
  • 10-19: 0.0 %
  • 20-29: 15.38 %
  • 30-39: 7.69 %
  • 40-49: 38.46 %
  • 50-59: 0.0 %
  • 60+: 30.77 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 28.57%
  2. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 4 people, 28.57%
  3. Insomnia (sleeplessness): 3 people, 21.43%
  4. T-Cell Lymphoma (a blood cell cancer): 2 people, 14.29%
  5. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 2 people, 14.29%
  6. B-Cell Type Acute Leukaemia (cancer of the white blood cells): 2 people, 14.29%
  7. Cholecystitis Acute (rapid infection of gallbladder): 2 people, 14.29%
  8. Enterococcal Infection: 2 people, 14.29%
  9. Systemic Candida (whole body fungal infection): 2 people, 14.29%
  10. Gastritis (inflammation of stomach): 2 people, 14.29%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Omeprazole: 5 people, 35.71%
  2. Amphotericin B: 4 people, 28.57%
  3. Meropenem: 4 people, 28.57%
  4. Cyclophosphamide: 3 people, 21.43%
  5. Zolpidem: 2 people, 14.29%
  6. Micafungin: 2 people, 14.29%
  7. Acyclovir: 2 people, 14.29%
  8. Amlodipine: 2 people, 14.29%
  9. Atovaquone: 2 people, 14.29%
  10. Daptomycin: 2 people, 14.29%

Other side effects people have besides Gastrointestinal candidiasis *:

You may use this to check any potential undetected side effects.

  1. Diarrhea: 4 people, 28.57%
  2. Gastric Perforation (hole in stomach): 4 people, 28.57%
  3. Drug Ineffective: 3 people, 21.43%
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 21.43%
  5. Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 2 people, 14.29%
  6. General Physical Health Deterioration (weak health status): 2 people, 14.29%
  7. Left Ventricular Failure (left ventricle fails to contract forcefully): 2 people, 14.29%
  8. Lung Disorder (lung disease): 2 people, 14.29%
  9. Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss): 2 people, 14.29%
  10. Nausea (feeling of having an urge to vomit): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of voriconazole, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.